Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Capital Group Llc Hopkins currently holds 3,696,523 shares of ACCENTIA BIOPHARMACEUTICALS INC (ABPI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Capital Group Llc Hopkins has been a net seller of ABPI stock. They have purchased $0 and sold $77.3K worth of shares.
Capital Group Llc Hopkins's most recent insider trade was on Sep 5, 2007, when they sold 15,459 shares at $5.00 per share.
Capital Group Llc Hopkins serves as Executive at ACCENTIA BIOPHARMACEUTICALS INC (ABPI). They have executed 4 insider transactions totaling $77.3K over their tenure at the company.
Capital Group Llc Hopkins holds the position of Executive at ACCENTIA BIOPHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Capital Group Llc Hopkins has shown a selling trading pattern, with $0 in total purchases and $77.3K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Capital Group Llc Hopkins was on Jan 10, 2007, when they purchased $158.7K worth of BDSI shares. This transaction involved 59,226 shares at $2.68 per share.
Capital Group Llc Hopkins currently owns 3,696,523 shares of ACCENTIA BIOPHARMACEUTICALS INC (ABPI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Capital Group Llc Hopkins's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Capital Group Llc Hopkins has 4 Form 4 filings on record as an insider at ACCENTIA BIOPHARMACEUTICALS INC.
Set alerts for Capital Group Llc Hopkins and 40,000+ other insiders.